|
|
Volumn 17, Issue 19, 1999, Pages 2321-2328
|
|
Novel adjuvants currently in clinical testing November 2-4, 1998, Fondation Merieux, Annecy, France: A meeting sponsored by the World Health Organization
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADJUVANT;
ALUMINUM POTASSIUM SULFATE;
ALUMINUM SALT;
ANTIBODY;
ANTIGEN;
CHORIONIC GONADOTROPIN BETA SUBUNIT;
DINUCLEOTIDE;
DNA VACCINE;
ENTEROTOXIN;
GLYCOPROTEIN GP 120;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HEPATITIS B SURFACE ANTIGEN;
IMMUNOGLOBULIN A;
IMMUNOMODULATING AGENT;
ISCOM;
LIPOSOME;
MALARIA VACCINE;
MURAMYL DIPEPTIDE;
N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE;
PHOSPHORYL LIPID A;
POLOXAMER;
POLYSORBATE 80;
QS 21;
RECOMBINANT INTERLEUKIN 2;
RECOMBINANT VACCINE;
SAPONIN;
SORBITAN TRIOLEATE;
TETANUS TOXOID;
UNINDEXED DRUG;
VACCINE;
ANAPHYLACTIC SHOCK;
ANTIBODY RESPONSE;
ANTIBODY TITER;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MECHANISM;
DRUG SAFETY;
HUMAN;
IMMUNE RESPONSE;
IMMUNIZATION;
IMMUNOGENICITY;
INTRANASAL DRUG ADMINISTRATION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
VACCINATION;
WORLD HEALTH ORGANIZATION;
ADJUVANTS, IMMUNOLOGIC;
CLINICAL TRIALS;
HUMANS;
VACCINES;
WORLD HEALTH ORGANIZATION;
|
|
EID: 0033553635
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(99)00021-3 Document Type: Conference Paper |
|
Times cited : (35)
|
|
References (15)
|
